المؤلفون: Archana Fernando, Hannah Warren, Kay Thomas, Conal Austin, Simon Chowdhury, Tim O'Brien

المصدر: BJU International. 124:462-468

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Urology, medicine.medical_treatment, Vena Cava, Inferior, Kidney, Thrombophilia, computer.software_genre, Nephrectomy, Inferior vena cava, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Interquartile range, Renal cell carcinoma, Humans, Medicine, 030212 general & internal medicine, Aged, Retrospective Studies, Aged, 80 and over, Database, business.industry, Cancer, Retrospective cohort study, Middle Aged, Prognosis, medicine.disease, Kidney Neoplasms, Surgery, medicine.vein, 030220 oncology & carcinogenesis, Cohort, Female, business, computer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::994ddbf3976b47bf657cd5e9a8724837Test
https://doi.org/10.1111/bju.14755Test

المؤلفون: Neeraj Agarwal, Frederique Baton, Patrick Werbrouck, Nicholas J. Vogelzang, Mihai Harza, Robert Huddart, Roberto Pili, Jean Christophe Pouget, Piotr Milecki, Andrew J. Armstrong, Gilberto Schwartsmann, Siobhan Ng, Simon Chowdhury, Arija Brize, Martin Bögemann, Thore Nederman, Nicholas D. James, Olexiy Lyulko, Thomas E. Hutson, Cora N. Sternberg, Remy Delva, A. Thanos, Michael A. Carducci, Enrique Gallardo, Helen Tuvesson, Denis Khvorostenko

المصدر: Journal of Clinical Oncology. 34:2636-2643

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Antineoplastic Agents, Quinolones, Placebo, law.invention, Tasquinimod, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, law, Internal medicine, medicine, Clinical endpoint, Humans, Neoplasm Metastasis, Aged, Aged, 80 and over, Random assignment, business.industry, Hazard ratio, Middle Aged, medicine.disease, Surgery, Clinical trial, Prostatic Neoplasms, Castration-Resistant, 030104 developmental biology, 030220 oncology & carcinogenesis, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f167c78f38a92ee7dc53f05c5083ecd5Test
https://doi.org/10.1200/jco.2016.66.9697Test

المؤلفون: Lauren C. Harshman, Ugo De Giorgi, Kevin Chan, Simon J. Crabb, Ulka N. Vaishampayan, Evan Y. Yu, Guru Sonpavde, Günter Niegisch, Cora N. Sternberg, Joaquim Bellmunt, Ali Reza Golshayan, Yu-Ning Wong, Sylvain Ladoire, Rafael Morales-Barrera, Syed A. Hussain, Ajjai Alva, Jonathan E. Rosenberg, Andrea Necchi, Simon Chowdhury, Matthew I. Milowsky, Gregory R. Pond, Daniel W. Bowles, Aristotelis Bamias, Jack Baniel, Matthew D. Galsky, Srikala S. Sridhar, Marc C. Smaldone, Sandy Srinivas, Dominik Berthold, Neeraj Agarwal, Sumanta K. Pal, Thomas Powles, Christine Theodore, Linda Cerbone, Rosalia Viterbo

المساهمون: Fondazione IRCCS Istituto Nazionale dei Tumori, McMaster University [Hamilton, Ontario], Fox Chase Cancer Center, City of Hope Comprehensive Cancer Center [Duarte], UAB Comprehensive Cancer Center UAB Comprehensive Cancer Center [Birmingham, AL, USA], University of Alabama at Birmingham [ Birmingham] (UAB), Dana-Farber Cancer Institute [Boston], University of Southampton, University of Michigan [Ann Arbor], University of Michigan System, Guy's and St Thomas' Hospital [London], Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Stanford School of Medicine [Stanford], Stanford Medicine, Stanford University-Stanford University, University of Utah School of Medicine [Salt Lake City], National and Kapodistrian University of Athens (NKUA), Rabin Medical Center - Beilinson and Hasharon Hospitals [Petach-Tikva, Israel], Medical University of South Carolina [Charleston] (MUSC), Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER, San Camillo Forlanini Hospital [Rome], University of Washington [Seattle], Karmanos Cancer Institute, Heinrich Heine Universität Düsseldorf = Heinrich Heine University [Düsseldorf], University of Liverpool, Vall d'Hebron Institute of Oncology [Barcelone] (VHIO), Vall d'Hebron University Hospital [Barcelona], University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), Hôpital Foch [Suresnes], Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), University of Toronto, Princess Margaret Hospital, Barts & The London School of Medicine, Memorial Sloane Kettering Cancer Center [New York], Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai [New York] (MSSM), Necchi, A, Pond, Gr, Smaldone, Mc, Pal, Sk, Chan, K, Wong, Yn, Viterbo, R, Sonpavde, G, Harshman, Lc, Crabb, S, Alva, A, Chowdhury, S, De Giorgi, U, Srinivas, S, Agarwal, N, Bamias, A, Baniel, J, Golshayan, Ar, Ladoire, S, Sternberg, Cn, Cerbone, L, Yu, Ey, Bellmunt, J, Vaishampayan, U, Niegisch, G, Hussain, S, Bowles, Dw, Morales-Barrera, R, Milowsky, Mi, Theodore, C, Berthold, Dr, Sridhar, S, Powles, T, Rosenberg, Je, Galsky, Md

المصدر: European Urology Focus
European Urology Focus, Elsevier, 2018, 4 (6), pp.937-945. ⟨10.1016/j.euf.2017.03.011⟩

مصطلحات موضوعية: Male, medicine.medical_treatment, 030232 urology & nephrology, Urinary Diversion, 0302 clinical medicine, Robotic Surgical Procedures, Interquartile range, Perioperative chemotherapy, Oncologists, Muscle invasive, Margins of Excision, Middle Aged, Prognosis, Neoadjuvant Therapy, 3. Good health, Survival Rate, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Urothelial carcinoma, medicine.medical_specialty, Urology, Antineoplastic Agents, [SDV.CAN]Life Sciences [q-bio]/Cancer, Cystectomy, Article, Disease-Free Survival, 03 medical and health sciences, medicine, Humans, Robot-assisted surgery, Neoplasm Invasiveness, Aged, Proportional Hazards Models, Retrospective Studies, Carcinoma, Transitional Cell, Chemotherapy, Bladder cancer, business.industry, Proportional hazards model, Muscle, Smooth, Retrospective cohort study, medicine.disease, Surgery, Logistic Models, Urinary Bladder Neoplasms, Multivariate Analysis, Lymph Node Excision, Muscle-invasive disease, Lymph Nodes, business

وصف الملف: text

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc30dcb8081be78c359d6685fc6fd8ebTest
https://hal.archives-ouvertes.fr/hal-01697161Test

المؤلفون: Kay Thomas, Hannah Warren, Conal Austin, Simon Chowdhury, Archana Fernando, Timothy O'Brien

المصدر: Journal of Urology. 199

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Urology, Peri, Renal surgery, Diaphragmatic breathing, Inferior vena cava, Surgery, medicine.anatomical_structure, medicine.vein, Long term survival, Medicine, Right atrium, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::492206941e91a5aca33847333cc6887eTest
https://doi.org/10.1016/j.juro.2018.02.2649Test

المؤلفون: Amit Bahl, Jérôme Alexandre, Gedske Daugaard, Michael Krainer, Benjamin Verret, Sylvestre Le Moulec, Ugo De Giorgi, Jean Marc Fererro, Tatiana Gavrikova, Sophie Hans, Aude Flechon, Alastair Thomson, Orazio Caffo, Frank Priou, Philippe Beuzeboc, Simon Chowdhury, Jean Laurent Deville, Brigitte Laguerre, Marine Gross Goupil, Eleni Efstathiou, Alison Birtle, Stéphane Oudard, Rafael Morales, Avishay Sella, Carole Helissey, Aline Guillot, Ali Hasbini, Anne-Claire Hardy-Bessard, Mohamed Butt, Dominique Spaeth, Antoine Thiery-Vuillemin, Karim Fizazi, Eric Lechevallier, Umberto Basso, Nicolas Delanoy, Giulia Baciarello, Jean-Christophe Eymard, Philippe Barthélémy

المصدر: European urology oncology. 1(6)

مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, medicine.drug_class, Urology, Abiraterone Acetate, Docetaxel, Disease-Free Survival, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Enzalutamide, Humans, Radiology, Nuclear Medicine and imaging, 030212 general & internal medicine, Aged, Retrospective Studies, business.industry, Abiraterone acetate, Middle Aged, Prostate-Specific Antigen, medicine.disease, Androgen, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, chemistry, Cabazitaxel, 030220 oncology & carcinogenesis, Toxicity, Multivariate Analysis, Surgery, Taxoids, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::390c1edc96186325014460a5018ac7fbTest
https://pubmed.ncbi.nlm.nih.gov/31158090Test

المؤلفون: Naomi B. Haas, Robert J. Motzer, Jae-Lyun Lee, Sergei Varlamov, Arnulf Stenzl, Toni K. Choueiri, Maurizio Voi, Bohuslav Melichar, Marine Gross-Goupil, Milada Zemanova, Weichao Bao, Christian Doehn, Ray McDermott, Evgeny Kopyltsov, Agnieszka Michael, Cora N. Sternberg, Paola Aimone, Lori Wood, Marlene Carrasco-Alfonso, Simon Chowdhury, F. Donskov, Brian I. Rini, Paul Russo, Ho Yeong Lim, M. Neil Reaume

المصدر: Motzer, R J, Haas, N B, Donskov, F, Gross-Goupil, M, Varlamov, S, Kopyltsov, E, Lee, J L, Melichar, B, Rini, B I, Choueiri, T K, Zemanova, M, Wood, L A, Reaume, M N, Stenzl, A, Chowdhury, S, Lim, H Y, McDermott, R, Michael, A, Bao, W, Carrasco-Alfonso, M J, Aimone, P, Voi, M, Doehn, C, Russo, P, Sternberg, C N & PROTECT investigators 2017, ' Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma ', Journal of Clinical Oncology, vol. 35, no. 35, pp. 3916-3923 . https://doi.org/10.1200/JCO.2017.73.5324Test

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Indazoles, medicine.medical_treatment, Clinical Trial, Phase III, 030232 urology & nephrology, Urology, Angiogenesis Inhibitors, Placebo, Nephrectomy, Disease-Free Survival, law.invention, Pazopanib, Placebos, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Randomized controlled trial, Renal cell carcinoma, law, medicine, Carcinoma, Clinical endpoint, Journal Article, Humans, Carcinoma, Renal Cell, Aged, Aged, 80 and over, Sulfonamides, Dose-Response Relationship, Drug, business.industry, Middle Aged, medicine.disease, Kidney Neoplasms, Surgery, Clinical trial, Multicenter Study, Pyrimidines, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Randomized Controlled Trial, Female, Neoplasm Grading, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ecd40e9ba0a4bb8a7c174b4b69b2fd5Test
https://pubmed.ncbi.nlm.nih.gov/29783587Test

المؤلفون: Matthew I. Milowsky, Federica Recine, Sumanta K. Pal, Matthew D. Galsky, Thomas Powles, Simon Chowdhury, Joaquim Bellmunt, Jihane Boustani, Matthieu Caubet, Aurélie Bertaut, Sylvain Ladoire, Gilles Créhange, Guenter Niegisch, Lauren C. Harshman, Ugo De Giorgi, Simon J. Crabb, Loïc Balssa, Jonathan E. Rosenberg, Evan Y. Yu

المساهمون: Service de Radiothérapie [CHRU Besançon], Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Unité de biostatistiques [Centre Georges-François Leclerc], Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai [New York] (MSSM), Memorial Sloane Kettering Cancer Center [New York], Dana-Farber Cancer Institute [Boston], Barts Cancer Institute, Queen Mary University of London (QMUL), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Guy's and St Thomas' Hospital [London], Heinrich Heine Universität Düsseldorf = Heinrich Heine University [Düsseldorf], University of Washington [Seattle], City of Hope Comprehensive Cancer Center [Duarte], University of Southampton, University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), Lineberger Comprehensive Cancer Center (UNC Lineberger), University of North Carolina System (UNC)-University of North Carolina System (UNC), Département d'oncologie médicale [Centre Georges-François Leclerc], Service de radiothérapie [Centre Georges-François Leclerc]

المصدر: Acta Oncologica
Acta Oncologica, Taylor & Francis, 2018, 57 (4), pp.491-497. ⟨10.1080/0284186X.2017.1369565⟩

مصطلحات موضوعية: Male, medicine.medical_specialty, medicine.medical_treatment, 030232 urology & nephrology, Urology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Kaplan-Meier Estimate, Cystectomy, Bladder preservation, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Carcinoma, medicine, Humans, Radiology, Nuclear Medicine and imaging, Proportional Hazards Models, Retrospective Studies, Aged, 80 and over, Carcinoma, Transitional Cell, Bladder cancer, business.industry, Proportional hazards model, Muscle invasive, Retrospective cohort study, Hematology, General Medicine, Chemoradiotherapy, medicine.disease, 3. Good health, Surgery, Treatment Outcome, Oncology, Urinary Bladder Neoplasms, 030220 oncology & carcinogenesis, Female, business

وصف الملف: text

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ada0014503252a4c7098bbafb31cdde0Test
https://pubmed.ncbi.nlm.nih.gov/28853615Test

المؤلفون: Yohann Loriot, S. Holmstrom, Cristina Ivanescu, Karim Fizazi, Frank Perabo, Celestia S. Higano, Tomasz M. Beer, Harry H. Mansbach, Bertrand Tombal, Kurt Miller, Konstantina Skaltsa, Cora N. Sternberg, De Phung, Simon Chowdhury, Sarah B. Noonberg, Johann S. de Bono

المصدر: The Lancet Oncology. 16:509-521

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, Visual analogue scale, Population, Pain, Placebo, Asymptomatic, Disease-Free Survival, law.invention, Prostate cancer, chemistry.chemical_compound, Double-Blind Method, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Nitriles, Phenylthiohydantoin, medicine, Humans, Enzalutamide, Neoplasm Metastasis, education, Aged, education.field_of_study, business.industry, Hazard ratio, Middle Aged, medicine.disease, Surgery, Prostatic Neoplasms, Castration-Resistant, Oncology, chemistry, Benzamides, Quality of Life, medicine.symptom, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3e3a4daf4caa7eb6bc0d5347ad188fbTest
https://doi.org/10.1016/s1470-2045Test(15)70113-0

المؤلفون: Daniel P Petrylak, Ronald de Wit, Kim N Chi, Alexandra Drakaki, Cora N Sternberg, Hiroyuki Nishiyama, Daniel Castellano, Syed Hussain, Aude Fléchon, Aristotelis Bamias, Evan Y Yu, Michiel S van der Heijden, Nobuaki Matsubara, Boris Alekseev, Andrea Necchi, Lajos Géczi, Yen-Chuan Ou, Hasan Senol Coskun, Wen-Pin Su, Miriam Hegemann, Ivor J Percent, Jae-Lyun Lee, Marcello Tucci, Andrey Semenov, Fredrik Laestadius, Avivit Peer, Giampaolo Tortora, Sufia Safina, Xavier Garcia del Muro, Alejo Rodriguez-Vida, Irfan Cicin, Hakan Harputluoglu, Ryan C Widau, Astra M Liepa, Richard A Walgren, Oday Hamid, Annamaria H Zimmermann, Katherine M Bell-McGuinn, Thomas Powles, Suet-Lai Shirley Wong, Thean Hsiang Tan, Elizabeth Jane Hovey, Timothy Dudley Clay, Siobhan Su Wan Ng, Annemie Rutten, Jean-Pascal Machiels, Herlinde Dumez, Susanna Yee-Shan Cheng, Kim Nguyen Chi, Cristiano Ferrario, Lisa Sengeloev, Niels Viggo Jensen, Constance Thibault, Brigitte Laguerre, Florence Joly, Aude Flechon, Stéphane Culine, Catherine Becht, Günter Niegisch, Michael Stöckle, Marc-Oliver Grimm, Georgios Gakis, Wolfgang Schultze-Seemann, Haralambos Kalofonos, Dimitrios Mavroudis, Christos Papandreou, Vasilis Karavasilis, Janos Révész, Lajos Geczi, Eli Rosenbaum, Raya Leibowitz-Amit, Daniel Kejzman, David Sarid, Giorgio Vittorio Scagliotti, Sergio Bracarda, Francesco Massari, Takahiro Osawa, Naoto Miyajima, Nobuo Shinohara, Fumimasa Fukuta, Chikara Ohyama, Wataru Obara, Shinichi Yamashita, Yoshihiko Tomita, Koji Kawai, Satoshi Fukasawa, Masafumi Oyama, Junji Yonese, Masayoshi Nagata, Motohide Uemura, Kazuo Nishimura, Mutsushi Kawakita, Hiroyuki Tsunemori, Katsuyoshi Hashine, Junichi Inokuchi, Akira Yokomizo, Satoshi Nagamori, Hyo Jin Lee, Se Hoon Park, Sun Young Rha, Yu Jung Kim, Yun-Gyoo Lee, Leticia Vazquez Cortés, Claudia Lorena Urzua Flores, Reinoud J B Blaisse, Fransiscus L G Erdkamp, Maureen J B Aarts, Joanna Wojcik-Tomaszewska, Piotr Tomczak, Bozena Sikora-Kupis, Michael Schenker, Alina Amalia Herzal, Anghel Adrian Udrea, Petr Karlov, Sufia Z Safina, Roman Fomkin, Enrique Grande Pulido, F Xavier García Del Muro, Juan Ignacio Delgado Mignorance, Daniel Castellano Gauna, Alejo Rodríguez-Vida, Yu-Li Su, Chien-Liang Lin, Chia-Chi Lin, Su-Peng Yeh, Irfan Çiçin, Mustafa Erman, Yuksel Urun, Yurii Golovko, Igor Bondarenko, Ivan Sinielnikov, Simon Crabb, Isabel Syndikus, Robert Huddart, Santhanam Sundar, Simon Chowdhury, Naveed Sarwar, Thomas Flaig, Chong Xian Pan, Daniel Petrylak, James Schwarz, Ivor Percent, Jennifer Cultrera, John Hainsworth, Benjamin Herms, William Lawler, Thomas Lowe, Scott Tagawa, Jeanny Aragon-Ching, Ulka Vaishampayan

المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service d'oncologie médicale, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Petrylak, Dp, de Wit, R, Chi, Kn, Drakaki, A, Sternberg, Cn, Nishiyama, H, Castellano, D, Hussain, S, Flechon, A, Bamias, A, Yu, Ey, van der Heijden, M, Matsubara, N, Alekseev, B, Necchi, A, Geczi, L, Ou, Yc, Coskun, H, Su, Wp, Hegemann, M, Percent, Ij, Lee, Jl, Tucci, M, Semenov, A, Laestadius, F, Peer, A, Tortora, G, Safina, S, del Muro, Xg, Rodriguez-Vida, A, Cicin, I, Harputluoglu, H, Widau, Rc, Liepa, Am, Walgren, Ra, Hamid, O, Zimmermann, Ah, Bell-McGuinn, Km, Powles, T, Medical Oncology

المصدر: Lancet (London, England), Vol. 390, no.10109, p. 2266-2277 (2017)
Lancet, 390(10109), 2266-2277. Elsevier Science
Lancet (UK), 390(10109), 2266-2277. Elsevier Ltd.

مصطلحات موضوعية: 0301 basic medicine, Male, Internationality, medicine.medical_treatment, Phases of clinical research, Docetaxel, Kaplan-Meier Estimate, Gastroenterology, 2ND-LINE THERAPY, 0302 clinical medicine, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, Medicine, ramucirab, Medicine (all), Antibodies, Monoclonal, General Medicine, Middle Aged, OPEN-LABEL, Prognosis, Neoadjuvant Therapy, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Taxoids, medicine.drug, Adult, medicine.medical_specialty, Metastatic Urothelial Carcinoma, Urology, Locally advanced, BLADDER-CANCER, Placebo, Antibodies, Monoclonal, Humanized, Risk Assessment, Ramucirumab, Antibodies, Disease-Free Survival, Double blind, II TRIAL, 03 medical and health sciences, LUNG-CANCER, Aged, Carcinoma, Transitional Cell, Double-Blind Method, Humans, Neoplasm Invasiveness, Neoplasm Staging, Proportional Hazards Models, Survival Analysis, Urinary Bladder Neoplasms, Internal medicine, BREAST-CANCER, In patient, Adverse effect, Platinum, Chemotherapy, FACTOR RECEPTOR-2, Settore MED/06 - ONCOLOGIA MEDICA, business.industry, Carcinoma, TRANSITIONAL-CELL-CARCINOMA, Surgery, Discontinuation, Regimen, Ramucirumab, docetaxel, 030104 developmental biology, ENDOTHELIAL GROWTH-FACTOR, Transitional Cell, business, FOLLOW-UP

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d65e42b670b576f5a3f43b55580726Test
https://hdl.handle.net/2078.1/275434Test

المؤلفون: Noan-Minh Chau, Alejo Rodriguez-Vida, Simon Chowdhury, Eleni Josephides, Myria Galazi

المصدر: Expert Review of Anticancer Therapy. 14:271-277

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Survival, medicine.medical_treatment, Population, Improved survival, Antineoplastic Agents, Nephrectomy, Targeted therapy, Renal cell carcinoma, Internal medicine, medicine, Humans, Pharmacology (medical), Cytoreductive nephrectomy, Neoplasm Metastasis, education, Carcinoma, Renal Cell, education.field_of_study, Performance status, business.industry, Patient Selection, Interferon-alpha, medicine.disease, Combined Modality Therapy, Primary tumor, Kidney Neoplasms, Surgery, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07fa2c9743c26112821712eb1c29f23Test
https://doi.org/10.1586/14737140.2014.864240Test